Literature DB >> 14761942

The effect of disease-associated mutations on the folding pathway of human prion protein.

Adrian C Apetri1, Krystyna Surewicz, Witold K Surewicz.   

Abstract

Propagation of transmissible spongiform encephalopathies is believed to involve the conversion of cellular prion protein, PrP(C), into a misfolded oligomeric form, PrP(Sc). An important step toward understanding the mechanism of this conversion is to elucidate the folding pathway(s) of the prion protein. We reported recently (Apetri, A. C., and Surewicz, W. K. (2002) J. Biol. Chem. 277, 44589-44592) that the folding of wild-type prion protein can best be described by a three-state sequential model involving a partially folded intermediate. Here we have performed kinetic stopped-flow studies for a number of recombinant prion protein variants carrying mutations associated with familial forms of prion disease. Analysis of kinetic data clearly demonstrates the presence of partially structured intermediates on the refolding pathway of each PrP variant studied. In each case, the partially folded state is at least one order of magnitude more populated than the fully unfolded state. The present study also reveals that, for the majority of PrP variants tested, mutations linked to familial prion diseases result in a pronounced increase in the thermodynamic stability, and thus the population, of the folding intermediate. These data strongly suggest that partially structured intermediates of PrP may play a crucial role in prion protein conversion, serving as direct precursors of the pathogenic PrP(Sc) isoform.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14761942     DOI: 10.1074/jbc.M313581200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Energy landscape of the prion protein helix 1 probed by metadynamics and NMR.

Authors:  Carlo Camilloni; Daniel Schaal; Kristian Schweimer; Stephan Schwarzinger; Alfonso De Simone
Journal:  Biophys J       Date:  2012-01-03       Impact factor: 4.033

2.  Real value prediction of protein folding rate change upon point mutation.

Authors:  Liang-Tsung Huang; M Michael Gromiha
Journal:  J Comput Aided Mol Des       Date:  2012-03-18       Impact factor: 3.686

Review 3.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

4.  Comparing the folding and misfolding energy landscapes of phosphoglycerate kinase.

Authors:  Gergely Agócs; Bence T Szabó; Gottfried Köhler; Szabolcs Osváth
Journal:  Biophys J       Date:  2012-06-19       Impact factor: 4.033

5.  Early intermediate in human prion protein folding as evidenced by ultrarapid mixing experiments.

Authors:  Adrian C Apetri; Kosuke Maki; Heinrich Roder; Witold K Surewicz
Journal:  J Am Chem Soc       Date:  2006-09-06       Impact factor: 15.419

6.  Folding kinetics of the human prion protein probed by temperature jump.

Authors:  Tanya Hart; Laszlo L P Hosszu; Clare R Trevitt; Graham S Jackson; Jonathan P Waltho; John Collinge; Anthony R Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-24       Impact factor: 11.205

7.  Prion disease susceptibility is affected by beta-structure folding propensity and local side-chain interactions in PrP.

Authors:  M Qasim Khan; Braden Sweeting; Vikram Khipple Mulligan; Pharhad Eli Arslan; Neil R Cashman; Emil F Pai; Avijit Chakrabartty
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

Review 8.  Prion diseases and their biochemical mechanisms.

Authors:  Nathan J Cobb; Witold K Surewicz
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

Review 9.  The consequences of pathogenic mutations to the human prion protein.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Protein Eng Des Sel       Date:  2009-07-14       Impact factor: 1.650

10.  Refinement of under-determined loops of Human Prion Protein by database-derived distance constraints.

Authors:  Feng Cui; Kriti Mukhopadhyay; Won-Bin Young; Robert L Jernigan; Zhijun Wu
Journal:  Int J Data Min Bioinform       Date:  2009       Impact factor: 0.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.